Impact In Progress is a podcast of Emory University’s Office of the Senior Vice President for Research, where we talk about Emory’s research, scholarship, and creative activity and the impact it’s having on the world around us in Atlanta, the state of Georgia, and beyond. Created and hosted by: Dr. Kimberly Eck with Victor Zamora, Dena Reinoso, Erica Pitre, and Chat With Leaders Media.

Impact In Progress
Claim This Podcastby Kimberly Eck
Podcast Overview
Impact In Progress is a podcast of Emory University’s Office of the Senior Vice President for Research, where we talk about Emory’s research, scholarship, and creative activity and the impact it’s having on the world around us in Atlanta, the state of Georgia, and beyond. Created and hosted by: Dr. Kimberly Eck with Victor Zamora, Dena Reinoso, Erica Pitre, and Chat With Leaders Media.
Language
🇺🇲
Publishing Since
8/27/2025
2 verified contact emails on file for Impact In Progress
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

May 5, 2026
Season 2 Close

April 21, 2026
S2E6 - Moving Research to the Bedside
<h1>Episode Notes</h1> <p><strong>Guest:</strong> Dr. Laurence Busse, Associate Professor, Emory University School of Medicine.</p> <p>Joining us is Dr. Laurence Busse, an Associate Professor in the Department of Medicine at the Emory University School of Medicine. Clinical trials are often restricted to large, urban academic centers, leaving community hospital patients without access to the latest treatments. Dr. Laurence Busse explains how the STAGE program (Satellite Trials Group of Emory) is mobilizing research, bringing life-saving trials for conditions like sepsis and pneumonia directly to the communities where patients live.</p> <p><strong>Key Takeaways:</strong></p> <ol> <li><strong>Access is Equity:</strong> Patients shouldn't have to travel hours to a main campus to participate in research. Making trials mobile ensures a more diverse and representative patient population.</li> <li><strong>The "Research Halo":</strong> Hospitals that conduct research generally provide a higher level of care for all patients, as the staff is constantly engaged with the newest clinical guidelines and advancements.</li> <li><strong>Innovating in Sepsis:</strong> Dr. Busse’s work includes novel approaches to treating septic shock by filtering endotoxins directly from the blood, a trial now available at community sites through STAGE.</li> </ol> <p><strong>Resources:</strong></p> <ul> <li><strong>Learn more abotu Dr. Laurence Busse</strong> - <a href="https://med.emory.edu/directory/profile/?u=LBUSSE" rel="nofollow">https://med.emory.edu/directory/profile/?u=LBUSSE</a></li> <li><strong>Learn more about STaGE (Satellite Trials Group of Emory)</strong> - <a href="https://med.aws.emory.edu/departments/medicine/divisions/pulmonary/research/the-satellite-trials-group-of-emory-stage.html" rel="nofollow">https://med.aws.emory.edu/departments/medicine/divisions/pulmonary/research/the-satellite-trials-group-of-emory-stage.html</a></li> </ul> <h3><strong>Follow the Show</strong></h3> <p>To stay updated on the latest research and impact at Emory, follow Impact in Progress on your favorite podcast platform, and if you are an Emory researcher interested in being featured, please reach out to Dr. Kimberly Eck at <a href="mailto:researchdevelopment@emory.edu" rel="nofollow"><strong>researchdevelopment@emory.edu</strong></a>.</p> <p>This podcast is powered by <a href="https://pinecast.com" rel="nofollow">Pinecast</a>.</p>

April 7, 2026
S2E5 - Biomarkers of Wasting Syndrome In Cancer Patients
<h1>Episode Notes</h1> <p>In this conversation, we sit down with Dr. Ronald Eldridge, an Assistant Professor at the Nell Hodgson Woodruff School of Nursing. For many cancer patients, the greatest threat isn't just the tumor—it's the involuntary loss of weight and muscle known as cachexia. Epidemiologist Dr. Ronald Eldridge discusses his research into identifying metabolic "early warning signs" to help clinicians intervene before a patient loses their strength and independence.</p> <p><strong>Key Takeaways:</strong></p> <ul> <li><strong>Understanding Cachexia:</strong> Cachexia accounts for roughly 30% of all cancer deaths. It is a metabolic disruption, not just "not eating enough," and is currently very difficult to reverse once it starts.</li> <li><strong>Early Intervention:</strong> Identifying biomarkers (like fatty acid and bile metabolites) can help clinicians predict which patients are at risk of severe weight loss before clinical symptoms appear.</li> <li><strong>Quality of Life:</strong> The goal of modern cancer research is shifting from simply "destroying the tumor" to ensuring the patient maintains the strength to live their life during and after treatment.</li> </ul> <p><strong>Resources:</strong></p> <ul> <li><a href="https://www.nursing.emory.edu/faculty-staff/ronald-eldridge" rel="nofollow">Dr. Ronald Eldridge - Emory Faculty Profile</a></li> <li><a href="https://www.nursing.emory.edu/" rel="nofollow">Nell Hodgson Woodruff School of Nursing</a></li> </ul> <p>This podcast is powered by <a href="https://pinecast.com" rel="nofollow">Pinecast</a>.</p>
15 total episodes available
Deep-dive analytics for Impact In Progress
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Impact In Progress?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.
